000 01348 a2200373 4500
005 20250512035457.0
264 0 _c19881012
008 198810s 0 0 eng d
022 _a0007-1048
024 7 _a10.1111/j.1365-2141.1988.tb02405.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGiles, A R
245 0 0 _aA combination of factor Xa and phosphatidylcholine-phosphatidylserine vesicles bypasses factor VIII in vivo.
_h[electronic resource]
260 _bBritish journal of haematology
_cAug 1988
300 _a491-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aDogs
650 0 4 _aFactor V
_xanalysis
650 0 4 _aFactor VIII
_xanalysis
650 0 4 _aFactor Xa
650 0 4 _aFibrinogen
650 0 4 _aHemophilia A
_xblood
650 0 4 _aPhosphatidylcholines
_xtherapeutic use
650 0 4 _aPhosphatidylserines
_xtherapeutic use
650 0 4 _aPlasminogen Activators
_xblood
650 0 4 _aProtein C
_xanalysis
650 0 4 _aProthrombin
_xanalysis
650 0 4 _aSerine Endopeptidases
_xtherapeutic use
700 1 _aMann, K G
700 1 _aNesheim, M E
773 0 _tBritish journal of haematology
_gvol. 69
_gno. 4
_gp. 491-7
856 4 0 _uhttps://doi.org/10.1111/j.1365-2141.1988.tb02405.x
_zAvailable from publisher's website
999 _c3142591
_d3142591